Enanta Pharmaceuticals Announces Update to its Hepatitis B Virus (HBV) Program
Go back to Enanta Pharmaceuticals Announces Update to its Hepatitis B Virus (HBV) Program| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 13.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.33 | 52 Week High | $34.49 | |||
| Open | $13.33 | 52 Week Low | $20.39 | |||
| Day High | $13.33 | P/E | N/A | |||
| Day Low | $13.33 | EPS | $-3.18 | |||
| Volume | 6,092 | |||||

